<DOC>
	<DOC>NCT01804205</DOC>
	<brief_summary>The purpose of this study is to evaluate the effects of MgSO4 administration on the pharmacodynamics of rocuronium in patients with 60 or more years of age.</brief_summary>
	<brief_title>Magnesium Sulphate and Rocuronium in Patients Over 60</brief_title>
	<detailed_description />
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<criteria>60 years or older ASA physical status IIII Scheduled for elective oncologic head and neck surgery Severe renal insufficiency (calculated creatinine clearance &lt; 30 ml/min) Preoperatory serum magnesium values &gt; 2.5 mEq/l Patients receiving medications known to affect neuromuscular function (furosemide, aminoglycoside, anticonvulsivants, calcio channel blocker, litium, azatioprine, cyclofosfamide)</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>magnesium sulfate</keyword>
	<keyword>rocuronium</keyword>
	<keyword>neuromuscular block</keyword>
	<keyword>onset time</keyword>
	<keyword>elderly</keyword>
</DOC>